ERYTECH Pharma a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the sale of its U.S. manufacturing facility to Catalent, a leading contract development and manufacturing organization (CDMO) in advanced therapies.
- Read more about ERYTECH Sells U.S. Manufacturing Facility and Enters Long - Term Supply Agreement with Catalent
- Log in or register to post comments
source https://www.pharmatutor.org/content/april-2022/erytech-sells-us-manufacturing-facility-and-enters-long-term-supply-agreement-with-catalent
No comments:
Post a Comment